Rigel Pharmaceuticals, Inc.
448 articles about Rigel Pharmaceuticals, Inc.
-
Rigel Pharmaceuticals, Inc. to Present at Wells Fargo Securities Healthcare Conference
6/16/2011
-
Rigel Pharmaceuticals, Inc. to Present at Jefferies and Co. Global Healthcare Conference
6/3/2011
-
Rigel Pharmaceuticals, Inc. Pockets $130 Million in Financing, Seeks To Pick up Pfizer Inc.'s Ball and Run With it
5/31/2011
-
Rigel Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock
5/26/2011
-
Rigel Pharmaceuticals, Inc. Announces Pricing of Public Offering of Common Stock
5/26/2011
-
Analysis: Big Pharmas Including Pfizer Inc. and Rigel Pharmaceuticals, Inc., Ditching Biotech Deals
5/17/2011
-
Rigel Pharmaceuticals, Inc. to Present at Bank of America Merrill Lynch Health Care Conference
5/6/2011
-
Rigel Pharmaceuticals, Inc. Says Pfizer Inc. Returns Asthma Therapy Rights
5/6/2011
-
Rigel Pharmaceuticals, Inc. Announces First Quarter Financial Results
5/3/2011
-
Rigel Pharmaceuticals, Inc. Announces Fourth Quarter and Year End 2010 Financial Results
3/1/2011
-
Rigel Pharmaceuticals, Inc. to Present at Three Upcoming Investor Conferences
2/28/2011
-
Rigel Pharmaceuticals, Inc. Announces Participation at Two Investor Conferences
2/9/2011
-
Rigel Pharmaceuticals, Inc. to Present at JP Morgan Healthcare Conference
1/6/2011
-
Rigel Pharmaceuticals, Inc. and AstraZeneca PLC Awarded 'Licensing Deal of the Year' by Scrip for Fostamatinib Collaboration
12/9/2010
-
Rigel Pharmaceuticals, Inc. to Present at Piper Jaffray Health Care Conference
11/23/2010
-
Rigel Pharmaceuticals, Inc. Announces Third Quarter 2010 Financial Results
11/2/2010
-
Rigel Pharmaceuticals, Inc. Announces Presentations at Two Investor Conferences
10/28/2010
-
Rigel Pharmaceuticals, Inc. Earns Milestone Payment Worth $25 Million From AstraZeneca PLC as Phase III Trial of Fostamatinib for Rheumatoid Arthritis is Initiated
9/29/2010
-
Data Published Today Reveal That Rigel Pharmaceuticals, Inc. and AstraZeneca PLC's Novel Oral Therapy Fostamatinib Demonstrates Positive Response in Rheumatoid Arthritis Patients
9/23/2010
-
Rigel Pharmaceuticals, Inc. Announces Second Quarter 2010 Financial Results
8/3/2010